PT-141 | 10mg

PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from the hormone alpha-MSH, with a molecular weight of 1025.18 g/mol. Unlike PDE5 inhibitors, PT-141 works centrally, activating MC3R and MC4R receptors in the hypothalamus to modulate the neural circuits involved in sexual arousal, independent of vascular mechanisms.

Research has examined PT-141 in male and female models of sexual dysfunction, with clinical studies demonstrating receptor-mediated effects on desire and arousal pathways. Its central mechanism of action offers researchers a distinct pharmacological profile for studying the neural basis of sexual response in both sexes.

Each Etched Research vial contains 10mg of lyophilized powder, purity-verified at ≥99% via HPLC and mass spectrometry. Batch-specific Certificate of Analysis included.

Specifications:
– Molecular Formula: C₅₀H₆₈N₁₄O₁₀
– Molecular Weight: 1025.18 g/mol
– Purity: ≥99% (HPLC + Mass Spectrometry)
– Form: Lyophilized powder
– Storage: -20°C (lyophilized); 4°C once reconstituted, use within 30 days

FOR IN VITRO RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, INGESTION, OR ANY IN VIVO USE.